ACSL4 and acute kidney injury: Recent research revealed that dexmedetomidine could attenuate ferroptosis-mediated IRI-induced AKI by inhibiting ACSL4 (Tao et al., 2022), and ACSL4 knockout also significantly alleviated this injury (Wang et al., 2022b).